Stock Events

Stock Events

BioAffinity Technologies 

$3.8
45
-$0.18-4.52% Today

Statistics

Day High
3.89
Day Low
3.59
52W High
25.83
52W Low
0.69
Volume
346,377
Avg. Volume
8,719,513
Mkt Cap
17.1M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-5.1
-1.41
2.29
5.98
Expected EPS
-2.4
Actual EPS
N/A

Financials

-96.56%Profit Margin
Unprofitable
2021
2022
2023
2024
18.72MRevenue
-18.08MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIAF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences Corp. offers cancer screening and diagnostic tests, directly competing with BioAffinity's diagnostic technologies for lung cancer and other diseases.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health, Inc. specializes in liquid biopsy tests, which overlaps with BioAffinity's non-invasive diagnostic approaches for cancer detection.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics, Inc. offers comprehensive genetic testing, in direct competition with BioAffinity's focus on early disease detection through biomarker analysis.
QuidelOrtho
QDEL
Mkt Cap1.83B
QuidelOrtho Corporation is involved in diagnostic healthcare, including cancer diagnostics, making it a competitor in the rapid diagnostic market.
Myriad Genetics
MYGN
Mkt Cap748.08M
Myriad Genetics, Inc. specializes in genetic testing and personalized medicine, competing in the same space as BioAffinity by offering diagnostic solutions for cancer.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Illumina
ILMN
Mkt Cap18.99B
Illumina, Inc. is a leading company in genomics and sequencing, which underpins the technological advancements in cancer diagnostics and research, indirectly competing with BioAffinity's approach to early detection and diagnosis.

About

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Show more...
CEO
Mr. Steven Girgenti
Employees
57
Country
US
ISIN
US09076W3079

Listings

XNAS
US
BIAF
XNAS
US
BIAFW
BOATS
BOATS
BIAF.BOATS

0 Comments

Share your thoughts

FAQ

What is BioAffinity Technologies stock price today?▼
The current price of BIAF is $3.8 USD — it has decreased by -4.52% in the past 24 hours. Watch BioAffinity Technologies stock price performance more closely on the chart.
What is BioAffinity Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioAffinity Technologies stocks are traded under the ticker BIAF.
Is BioAffinity Technologies stock price growing?▼
BIAF stock has fallen by -18.57% compared to the previous week, the month change is a +264.15% rise, over the last year BioAffinity Technologies has showed a -85.54% decrease.
What is BioAffinity Technologies market cap?▼
Today BioAffinity Technologies has the market capitalization of 17.1M
When is the next BioAffinity Technologies earnings date?▼
BioAffinity Technologies is going to release the next earnings report on May 20, 2026.
What were BioAffinity Technologies earnings last quarter?▼
BIAF earnings for the last quarter are 5.98 USD per share, whereas the estimation was -2.7 USD resulting in a +321.48% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioAffinity Technologies revenue for the last year?▼
BioAffinity Technologies revenue for the last year amounts to 18.72M USD.
What is BioAffinity Technologies net income for the last year?▼
BIAF net income for the last year is -18.08M USD.
How many employees does BioAffinity Technologies have?▼
As of April 02, 2026, the company has 57 employees.
In which sector is BioAffinity Technologies located?▼
BioAffinity Technologies operates in the Health Care sector.
When did BioAffinity Technologies complete a stock split?▼
The last stock split for BioAffinity Technologies was on September 19, 2025 with a ratio of 1:30.
Where is BioAffinity Technologies headquartered?▼
BioAffinity Technologies is headquartered in San Antonio, US.